
201 - 500 employees
Founded 1998
🏥 Healthcare
🧬 Biotechnology
💊 Pharmaceuticals
💰 $4.1M Post-IPO Equity - Zealand Pharma on 2025-06
Healthcare • Biotechnology • Pharmaceuticals
Zealand Pharma is an international biotechnology company headquartered in Denmark with operations in Boston, USA. It discovers, designs, and develops peptide-based and small-molecule medicines focused on transforming metabolic health—particularly obesity—and on treating rare diseases such as congenital hyperinsulinism and short bowel syndrome, as well as chronic inflammatory conditions. Zealand Pharma maintains a clinical-stage R&D pipeline (including petrelintide, survodutide, glepaglutide, ZP9830, and others), engages in partnerships to advance development and commercialization, and is publicly listed on Nasdaq Copenhagen.
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🔥 2 hours ago
Director leading Zealand Pharma’s US obesity-focused MSL team for obesity and metabolic health medicines. Driving field strategy, KOL engagement, launch readiness, and team development across the US.
🇺🇸 United States – Remote
💰 $4.1M Post-IPO Equity - Zealand Pharma on 2025-06
⏰ Full Time
🔴 Lead
👔 Director
👻 Ghost score 12%